4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-25-014849
Director sold 69,219 shares at $0.78 ($53,991)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahadevia Ankit Director | 2025-02-05 | Sale | −13,959 | $0.78 | $10,888 | 745,126 | D |
| Mahadevia Ankit Director | 2025-02-05 | Sale | −55,260 | $0.78 | $43,103 | 689,866 | D |
| Open-market sales · 69,219 sh · avg $0.78 · $53,991 | |||||||
Loading xslF345X05/ownership.xml…